Microneedle-based intradermal delivery of stabilized dengue virus.
Ontology highlight
ABSTRACT: Current live-attenuated dengue vaccines require strict cold chain storage. Methods to preserve dengue virus (DENV) viability, which enable vaccines to be transported and administered at ambient temperatures, will be decisive towards the implementation of affordable global vaccination schemes with broad immunization coverage in resource-limited areas. We have developed a microneedle (MN)-based vaccine platform for the stabilization and intradermal delivery of live DENV from minimally invasive skin patches. Dengue virus-stabilized microneedle arrays (VSMN) were fabricated using saccharide-based formulation of virus and could be stored dry at ambient temperature up to 3 weeks with maintained virus viability. Following intradermal vaccination, VSMN-delivered DENV was shown to elicit strong neu
SUBMITTER: Turvey ME
PROVIDER: S-EPMC6584444 | biostudies-literature | 2019 May
REPOSITORIES: biostudies-literature
ACCESS DATA